Cureschil Pharmaceuticals Private Limited
About Cureschil Pharmaceuticals Private Limited
Data last updated:
Cureschil Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 04 February 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2020PTC361349.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Vishwa Nath Singh and Jitendra Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 1/190 – A G/F Madhu Vihar Uttam Nagar, Delhi, India – 110059.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.13 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net profit of ₹1.16 Lakh (net margin 1%) and EBITDA of ₹2.72 Lakh (EBITDA margin 2.4%). Revenue has grown at a compounded annual rate (CAGR) of 38% over three years.
Company details
Contact details
Cureschil Pharmaceuticals Private Limited's registered office is in Delhi, Delhi.
- Registered AddressC – 1/190 – A G/F Madhu Vihar Uttam Nagar, Delhi, India – 110059
- IndustryChemicals, Manufacturing, Basic Chemical
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cureschil Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Cureschil Pharmaceuticals Private Limited, buy the company report.
Financials of Cureschil Pharmaceuticals Private Limited
FY 2025 filings availableCureschil Pharmaceuticals Private Limited reported revenue of ₹1.13 Cr (up 23% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 38% over three years, including 23% growth in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.72 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.16 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.4% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cureschil Pharmaceuticals Private Limited, buy the company report.
Board of directors of Cureschil Pharmaceuticals Private Limited
Cureschil Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vishwa Nath Singh | Director | 04 Feb 2020 | 6 Years 8 Months | Current |
| Jitendra Singh | Director | 04 Feb 2020 | 6 Years 8 Months | Current |
| Arti Trivedi | Director | 04 Feb 2020 | 6 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving Cureschil Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cureschil Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Cureschil Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Cureschil Pharmaceuticals Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Arti Trivedi was appointed as Director on 04 Feb 2020.
Frequently asked questions
Cureschil Pharmaceuticals is an active private limited company based in Delhi, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 04 February 2020 (6+ years old) and is registered under CIN U24100DL2020PTC361349.
Cureschil Pharmaceuticals has 3 current directors:
- Vishwa Nath Singh - Director
- Jitendra Singh - Director
- Arti Trivedi - Director
The latest financial statements of Cureschil Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Cureschil Pharmaceuticals is U24100DL2020PTC361349. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cureschil Pharmaceuticals was incorporated on 04 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
Arti Trivedi was appointed as Director on 04 Feb 2020. Jitendra Singh was appointed as Director on 04 Feb 2020. Vishwa Nath Singh was appointed as Director on 04 Feb 2020.
The registered office of Cureschil Pharmaceuticals is at C – 1190 – A GF Madhu Vihar Uttam Nagar, Delhi, India – 110059.
Cureschil Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Cureschil Pharmaceuticals can be reached at its registered office: C – 1190 – A GF Madhu Vihar Uttam Nagar, Delhi, India – 110059.
Cureschil Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.